To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines

Industry News & Events

23rd November 2022

Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders. Last week the CJEU published its keenly awaited judgments concerning several well-known pharmaceutical companies which provide welcome guidance. Read the article in full on BioTalk here.

Tagged with: , , ,

Guillaume de Villegas

I am a counsel in our Brussels office where I have experience in all types of IP matters, with a particular focus on trade mark, copyright, design and patent law in the life sciences, retail & consumer, food & beverage, luxury goods and media & entertainment sectors.

Profile Email

Silke Fiers

I'm an associate in our Brussels Intellectual Property Group. I advise clients from various IP-heavy industries on their IP strategy and disputes, both in Belgian as well as cross-border matters.

Profile Email

Popular

Trade Mark reports for CIPA Journal

Don’t get too comfortable – Community Trade Marks will usually require use in more than one member state, says UK Court

Border enforcement in Singapore – being prepared for the upcoming ASEAN Economic Community

Reform of the CTM system: What you need to know

Related Stories

Browse more articles in Industry News & Events